These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19695867)

  • 1. The challenges of organising cervical screening programmes in the 15 old member states of the European Union.
    Arbyn M; Rebolj M; De Kok IM; Fender M; Becker N; O'Reilly M; Andrae B
    Eur J Cancer; 2009 Oct; 45(15):2671-8. PubMed ID: 19695867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union.
    Nicula FA; Anttila A; Neamtiu L; Zakelj MP; Tachezy R; Chil A; Grce M; Kesić V
    Eur J Cancer; 2009 Oct; 45(15):2679-84. PubMed ID: 19699083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Description of the national situation of cervical cancer screening in the member states of the European Union.
    Anttila A; Ronco G;
    Eur J Cancer; 2009 Oct; 45(15):2685-708. PubMed ID: 19744852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening in Europe: Quality assurance and organisation of programmes.
    Elfström KM; Arnheim-Dahlström L; von Karsa L; Dillner J
    Eur J Cancer; 2015 May; 51(8):950-68. PubMed ID: 25817010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of human papillomavirus vaccination and screening in Spain.
    Diaz M; de Sanjose S; Ortendahl J; O'Shea M; Goldie SJ; Bosch FX; Kim JJ
    Eur J Cancer; 2010 Nov; 46(16):2973-85. PubMed ID: 20638840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination.
    Lynge E; Antilla A; Arbyn M; Segnan N; Ronco G
    Eur J Cancer; 2009 Oct; 45(15):2714-21. PubMed ID: 19695870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implementation status of cervical screening in Europe].
    Döbrőssy L; Cornides A; Kovács A; Budai A
    Orv Hetil; 2014 Dec; 155(50):1975-88. PubMed ID: 25481500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document.
    Arbyn M; Anttila A; Jordan J; Ronco G; Schenck U; Segnan N; Wiener H; Herbert A; von Karsa L
    Ann Oncol; 2010 Mar; 21(3):448-458. PubMed ID: 20176693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Process performance of cervical screening programmes in Europe.
    Ronco G; van Ballegooijen M; Becker N; Chil A; Fender M; Giubilato P; Kurtinaitis J; Lancucki L; Lynge E; Morais A; O'Reilly M; Sparen P; Suteu O; Rebolj M; Veerus P; Zakelj MP; Anttila A
    Eur J Cancer; 2009 Oct; 45(15):2659-70. PubMed ID: 19713100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified screening among high risk women within the organised screening programme for cervical cancer in Finland.
    Kotaniemi-Talonen L; Malila N; Anttila A; Nieminen P; Hakama M
    Acta Oncol; 2011 Jan; 50(1):106-11. PubMed ID: 20560860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical carcinoma in the European Union: an update on disease burden, screening program state of activation, and coverage as of March 2014.
    Altobelli E; Lattanzi A
    Int J Gynecol Cancer; 2015 Mar; 25(3):474-83. PubMed ID: 25695550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening policies and coverage in Europe.
    Anttila A; von Karsa L; Aasmaa A; Fender M; Patnick J; Rebolj M; Nicula F; Vass L; Valerianova Z; Voti L; Sauvaget C; Ronco G
    Eur J Cancer; 2009 Oct; 45(15):2649-58. PubMed ID: 19699081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2009; 33(3 Suppl 2):41-56. PubMed ID: 19776486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer prevention: An Italian scenario between organised screening and human papillomaviruses vaccination.
    Cappelli MG; Fortunato F; Tafuri S; Boccalini S; Bonanni P; Prato R; Martinelli D
    Eur J Cancer Care (Engl); 2018 Sep; 27(5):e12905. PubMed ID: 30178893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organised screening for cervical cancer in France: a cost-effectiveness assessment.
    Barré S; Massetti M; Leleu H; De Bels F
    BMJ Open; 2017 Oct; 7(10):e014626. PubMed ID: 28988162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring and evaluation of a model demonstration project for the control of cervical cancer in Nakhon Phanom province, Thailand.
    Deerasamee S; Srivatanakul P; Sriplung H; Nilvachararung S; Tansuwan U; Pitakpraiwan P; Kaewkungwal J; Singhasivanon P; Nimnakorn P; Sankaranarayanan R
    Asian Pac J Cancer Prev; 2007; 8(4):547-56. PubMed ID: 18260727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.